text
"['\n4. 매출 및 수주상황\n가. 매출실적\n\xa0 \xa0 \xa0 ( 단위 : 백만원 )\n구분\n사업부문\n품목\n구분\n제51 기\n제50 기\n제49 기\n계속영업사업\n산업설비공사\n산업설비플랜트E.P.C\n수출\n1,181\n1,723\n2,514\n내수\n70,505\n70,098\n54,274\n합계\n71,686\n71,821\n56,788\n화장품\n노보스트라타 등\n수출\n-\n-\n-\n내수\n402\n649\n1,948\n합계\n402\n649\n1,948\n건강식품\n스위치온 등\n수출\n-\n-\n-\n내수\n1,253\n-\n-\n합계\n1,253\n-\n-\n셀론텍\n리젠씰, 카티졸 등\n수출\n-\n-\n-\n내수\n2,345\n-\n-\n합계\n2,345\n-\n-\n기타\n젠바디 등\n수출\n-\n-\n-\n내수\n39\n-\n-\n합계\n39\n-\n-\n소계\n수출\n1,181\n1,723\n2,514\n내수\n74,544\n70,747\n56,222\n합계\n75,725\n72,470\n58,736\n중단영업사업\n세원셀론텍_PE\n열교환기, 반응기 등\n수출\n-\n42,401\n127,866\n내수\n-\n8,722\n20,040\n합계\n-\n51,123\n147,906\n세원셀론텍_PL\nVALVE 등\n수출\n-\n10\n62\n내수\n-\n2,713\n6,635\n합계\n-\n2,723\n6,697\n세원셀론텍_RMS\n세포치료제, 가족제대혈은행\n수출\n-\n163\n538\n내수\n-\n12,216\n26,558\n합계\n-\n12,379\n27,096\n상해세원액압유한공사\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n179\n238\n합계\n-\n179\n238\n셀론텍\n콘드론, 오스론, 베이비셀\n수출\n-\n내수\n147\n합계\n147\n소계\n수출\n-\n42,574\n128,466\n내수\n147\n23,830\n53,471\n합계\n147\n66,404\n181,937\n나. 수주상황\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n기초\n증감액\n공사수익인식\n기말\n산업설비공사\n48,699,168\n133,184,377\n78,522,983\n103,360,562\n다. 진행률적용 수주상황\n(단위 : 천원)\n계약처\n계약일자\n계약상완성기한\n진행율\n수주총액\n계약자산\n매출채권\n총액\n손상차손누계액\n총액\n대손충당금\n머크버슘머트리얼즈코리아㈜\n20/12/02\n22/03/31\n91%\n7,185,000\n-\n-\n1,428,900\n-\n노루홀딩스\n21/03/29\n22/01/25\n92%\n3,410,000\n-\n-\n349,044\n-\n금호피앤비화학㈜\n21/03/23\n22/01/31\n98%\n7,680,000\n-\n-\n1,210,110\n-\n스미세이케미칼㈜\n21/04/01\n22/03/31\n51%\n15,570,000\n1,431,638\n-\n2,659,580\n-\n한화솔루션\n21/04/06\n22/09/30\n26%\n32,720,069\n-\n-\n2,011,961\n-\n금호미쓰이화학㈜\n21/06/29\n22/12/31\n24%\n29,910,000\n-\n-\n1,332,045\n-\n삼양이노켐㈜\n21/08/18\n22/02/28\n64%\n6,540,000\n-\n-\n1,624,093\n-\n티이엠씨 주식회사\n21/11/16\n22/06/30\n10%\n5,150,000\n-\n-\n2,064,480\n-\n금호석유화학(주)여수정밀화학\n21/12/17\n23/06/30\n0%\n22,490,000\n-\n-\n-\n-\n']"
